The store will not work correctly when cookies are disabled.
4-hydroxy-3-(1-(4-iodophenyl)-3-oxobutyl)-2H-chromen-2-one
ID: ALA4554026
Cas Number: 5543-62-4
PubChem CID: 54678499
Max Phase: Preclinical
Molecular Formula: C19H15IO4
Molecular Weight: 434.23
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: CC(=O)CC(c1ccc(I)cc1)c1c(O)c2ccccc2oc1=O
Standard InChI: InChI=1S/C19H15IO4/c1-11(21)10-15(12-6-8-13(20)9-7-12)17-18(22)14-4-2-3-5-16(14)24-19(17)23/h2-9,15,22H,10H2,1H3
Standard InChI Key: PFHMVMIFNQXMFI-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
12.3184 -4.4202 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3172 -5.2398 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0253 -5.6487 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0235 -4.0114 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7321 -4.4166 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7309 -5.2373 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4371 -5.6463 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.1490 -5.2393 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1502 -4.4186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4394 -4.0050 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8556 -5.6498 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.4395 -3.1878 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.8589 -4.0117 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5656 -4.4221 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8608 -3.1946 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5717 -2.7895 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5740 -1.9731 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8668 -1.5619 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1557 -1.9732 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1569 -2.7883 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8677 -0.7447 0.0000 I 0 0 0 0 0 0 0 0 0 0 0 0
17.2743 -4.0152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9810 -4.4255 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2763 -3.1980 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
5 10 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
8 11 2 0
10 12 1 0
9 13 1 0
13 14 1 0
13 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
18 21 1 0
14 22 1 0
22 23 1 0
22 24 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 434.23 | Molecular Weight (Monoisotopic): 434.0015 | AlogP: 4.21 | #Rotatable Bonds: 4 |
Polar Surface Area: 67.51 | Molecular Species: ACID | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 5.09 | CX Basic pKa: ┄ | CX LogP: 3.67 | CX LogD: 1.48 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.49 | Np Likeness Score: 0.02 |
References
1. Dalvit C, Vulpetti A.. (2019) Ligand-Based Fluorine NMR Screening: Principles and Applications in Drug Discovery Projects., 62 (5): [PMID:30295487] [10.1021/acs.jmedchem.8b01210] |